|
Market Closed -
Nasdaq
16:00:00 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 1.170 USD | +2.63% |
|
-4.10% | -49.79% |
| 10-26 | Spero Therapeutics, Inc. Announces Executive Changes | CI |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart calendar Spero Therapeutics, Inc.
Upcoming events on Spero Therapeutics, Inc.
No events available
Past events on Spero Therapeutics, Inc.
| 2026-08-12 | Earnings presentation | 17:00 |
| 2026-08-12 | Earnings release - Q2 2026 | |
| 2026-06-23 | Annual General Meeting | 09:00 |
| 2026-06-23 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-05-13 | Earnings release - Q1 2026 | |
| 2026-03-26 | Earnings release - Q4 2025 | |
| 2025-11-13 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 104 48,9 112.29% | 48,0 39,0 23.12% | 0,00 0,00 - | 0,26 | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 21,5 -34,5 162.35% | -73,4 -69,1 -6.22% | 0,00 0,00 - | -36,7 | -55,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 25,4 -25,9 197.95% | -68,6 -66,7 -2.77% | 0,00 0,00 - | -33,5 | -51,5 |
|
Net income Million USD | Released Forecast Spread | 22,8 -33,7 167.75% | -68,6 -64,8 -5.79% | 0,00 0,00 - | -33,5 | -51,5 |
|
EPS USD | Released Forecast Spread | 0,43 -0,69 162.55% | -1,27 -0,92 -38.04% | 0,15 -0,10 250% | -0,58 | -0,11 |
| Announcement Date | 13/03/24 | 27/03/25 | 26/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15,0 6,20 142.65% | 5,87 0,00 - | 14,2 0,00 - | 5,44 0,00 - | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -21,7 -17,3 -25.94% | -14,6 -30,5 52.28% | -2,44 -21,2 88.47% | -7,92 -14,4 45.03% | -9,50 | -9,70 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,6 -18,8 -9.86% | -8,40 | -8,30 | |||
|
Net income Million USD | Released Forecast Spread | -20,9 -16,8 -24.15% | -13,9 -30,5 54.54% | -1,70 -21,2 91.98% | -7,38 -14,4 48.74% | -8,40 | -8,30 |
|
EPS USD | Released Forecast Spread | -0,38 -0,31 -22.58% | -0,25 -0,55 54.55% | -0,03 -0,38 92.11% | -0,13 -0,25 48% | -0,14 | -0,14 |
| Announcement Date | 27/03/25 | 13/05/25 | 12/08/25 | 13/11/25 | - | - |
| Today |  | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 08:00 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 17:00 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Earnings release - Q3 2026 | |
| 2026-10-30 | | Extraordinary General Meeting | 04:00 |
Past sector events for Spero Therapeutics, Inc.
| 2026-10-28 | | Information meeting | 12:00 |
| Today | | Board of Directors Meeting | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| 2026-10-28 | | Earnings presentation | 16:30 |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| 2026-10-27 | | Earnings release - Q3 2026 | |
| 2026-10-27 | | Information meeting | 08:30 |
| 2026-10-27 | | Information meeting | 08:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPRO Stock
- Calendar Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
